Literature DB >> 12079620

Physiological and therapeutic roles of peroxisome proliferator-activated receptors.

Joel Berger1, John A Wagner.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor isoforms, including PPARgamma, PPARalpha, and PPARdelta, encoded by different genes. PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters. PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with cofactors increasing the rate of transcription initiation. The PPARs play a critical physiological role as lipid sensors and regulators of lipid metabolism. Natural ligands for the PPARs include fatty acids and eicosanoids. More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, are effective in the treatment of dyslipidemia and diabetes. Use of selective ligands led to the discovery of additional potential roles for the PPARs in pathological states, including atherosclerosis, inflammation, and hypertension. This review provides an overview of the molecular mechanisms of PPAR action and the involvement of the PPARs in the etiology and treatment of several chronic diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079620     DOI: 10.1089/15209150260007381

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  29 in total

Review 1.  Significance of anti-inflammatory effects of PPARgamma agonists?

Authors:  G Rogler
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  PPARdelta agonism inhibits skeletal muscle PDC activity, mitochondrial ATP production and force generation during prolonged contraction.

Authors:  Dumitru Constantin-Teodosiu; David J Baker; Despina Constantin; Paul L Greenhaff
Journal:  J Physiol       Date:  2008-11-10       Impact factor: 5.182

3.  Conjugated linoleic acid reduced metastasized LL2 tumors in mouse peritoneum.

Authors:  Yasuha Sakai; Tomonori Sasahira; Hitoshi Ohmori; Kazuhiro Yoshida; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2006-08-08       Impact factor: 4.064

4.  Analgesic tolerance to morphine is regulated by PPARγ.

Authors:  Giordano de Guglielmo; Marsida Kallupi; Giulia Scuppa; Serena Stopponi; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.

Authors:  Martijn van Doorn; Michiel Kemme; Margriet Ouwens; Ewoud J van Hoogdalem; Richard Jones; Hans Romijn; Marieke de Kam; Rik Schoemaker; Koos Burggraaf; Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

6.  Automated hydrogen/deuterium exchange electron transfer dissociation high resolution mass spectrometry measured at single-amide resolution.

Authors:  Rachelle R Landgraf; Michael J Chalmers; Patrick R Griffin
Journal:  J Am Soc Mass Spectrom       Date:  2011-12-01       Impact factor: 3.109

7.  Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.

Authors:  Jean W Lee; Russ S Weiner; Jeff M Sailstad; Ronald R Bowsher; Dean W Knuth; Peter J O'Brien; Jean L Fourcroy; Rakesh Dixit; Lini Pandite; Robert G Pietrusko; Holly D Soares; Valerie Quarmby; Ole L Vesterqvist; David M Potter; James L Witliff; Herbert A Fritche; Timothy O'Leary; Lorah Perlee; Sunil Kadam; John A Wagner
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

8.  A combined ligand- and structure-based virtual screening protocol identifies submicromolar PPARγ partial agonists.

Authors:  Dušica Vidović; Scott A Busby; Patrick R Griffin; Stephan C Schürer
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

9.  PPARγ is an E3 ligase that induces the degradation of NFκB/p65.

Authors:  Yongzhong Hou; France Moreau; Kris Chadee
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.

Authors:  Vikas Chandra; Pengxiang Huang; Yoshitomo Hamuro; Srilatha Raghuram; Yongjun Wang; Thomas P Burris; Fraydoon Rastinejad
Journal:  Nature       Date:  2008-11-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.